Stock BRETEC BIORETEC OY
Add to a list
To use this feature you must be a member
Log inSign up

Bioretec Oy Stock

Equities

BRETEC

FI4000480454

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki
Other stock markets
 11:20:01 2024-05-03 EDT 		5-day change 1st Jan Change
2.61 EUR +1.95% Intraday chart for Bioretec Oy -1.51% +8.75%
04-05 Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors CI
03-22 Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition MT

Financials

Sales 2023 3.91M 4.2M 5.75M Sales 2024 * 5.9M 6.35M 8.69M Capitalization 53.08M 57.12M 78.16M
Net income 2023 -3M -3.23M -4.42M Net income 2024 * -3M -3.23M -4.42M EV / Sales 2023 13.6 x
Net cash position 2023 * 5.8M 6.24M 8.54M Net cash position 2024 * 1.6M 1.72M 2.36M EV / Sales 2024 * 8.73 x
P/E ratio 2023
-13.7 x
P/E ratio 2024 *
-17.4 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 64.06%
More Fundamentals * Assessed data

Chart Bioretec Oy

Dynamic Chart

Latest news about Bioretec Oy

Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition MT
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition CI
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant MT
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2 MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation CI
Bioretec to Initiate Search for New CEO MT
Bioretec Ltd Announces CEO Changes CI
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024 CI
Bioretec Secures Distribution Agreement for Trauma Screws in US Market MT
Bioretec Signs Distribution Deal for Launch of Orthopedic Product in US MT
Bioretec Ltd. Enters into the U.S. Distribution Agreement with Spartan Medical Inc. for the RemeOs Screws CI
Bioretec Wins R&D Grant from Business Finland for Developing Advanced Biodegradable Implants MT
Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board CI
More news

Press releases Bioretec Oy

Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd AQ
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office AQ
Bioretec Ltd's Annual Report and Financial Statements 2023 published AQ
More press releases

Quotes and Performance

1 day+1.95%
1 week-1.51%
Current month+0.77%
1 month-7.12%
3 months+10.13%
6 months+9.21%
Current year+8.75%
More quotes

Highs and lows

1 week
2.49
Extreme 2.49
2.67
1 month
2.49
Extreme 2.49
2.90
Current year
2.14
Extreme 2.14
2.90
1 year
2.02
Extreme 2.02
2.90
3 years
1.25
Extreme 1.245
3.75
5 years
1.25
Extreme 1.245
3.75
10 years
1.25
Extreme 1.245
3.75
More quotes

Managers and Directors - Bioretec Oy

Managers TitleAgeSince
Timo Lehtonen CEO
 Chief Executive Officer 49 19-02-28
Johanna Maarit Salko DFI
 Director of Finance/CFO 57 21-01-31
Tomi Juhani Numminen CHM
 Chairman 53 16-04-30
Members of the board TitleAgeSince
Tomi Juhani Numminen CHM
 Chairman 53 16-04-30
Pekka Ilmari Simula BRD
 Director/Board Member 50 19-12-31
Michael Piccirillo BRD
 Director/Board Member 65 17-12-31
More insiders

Quotes

Date Price Change Volume
24-05-03 2.61 +1.95% 33,510
24-05-02 2.56 -1.16% 23,306
24-04-30 2.59 -1.52% 10,565
24-04-29 2.63 -1.50% 18,025
24-04-26 2.67 +0.75% 8,190

Delayed Quote Nasdaq Helsinki, May 03, 2024 at 11:20 am

More quotes

Company Profile

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-15 - Q1 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Bioretec Oy

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.61 EUR
Average target price
3.75 EUR
Spread / Average Target
+43.68%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
BIORETEC OY Stock Bioretec Oy
+8.75% 55.7M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.37% 12.38B
PENUMBRA, INC. Stock Penumbra, Inc.
-17.09% 7.99B
MASIMO CORPORATION Stock Masimo Corporation
+16.88% 7.21B
GETINGE AB Stock Getinge AB
+3.57% 5.79B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+11.77% 5.35B
APT MEDICAL INC. Stock APT Medical Inc.
+29.65% 4.63B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-17.74% 4.17B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-35.26% 2.44B
SKAN GROUP AG Stock SKAN Group AG
+3.09% 2.03B
Medical Equipment
  1. Stock Market
  2. Equities
  3. BRETEC Stock